demonstrated that Treg specific ablation of the IL-33 receptor ST2 diminished the KLRG1+CD103+ Tregs, induced CD8+ T cell infiltration, and reduced the tumor burden, highlighting the dominant immunosuppressive and tumor promoting characteristics of this Treg subpopulation in lung cancer (92). This evidence concerns the gene KLRG1 and neoplasm.